Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Oral minoxidil improved male baldness, but had side effects; certain antibiotics effectively treated a rare scalp condition; hair transplants might trigger another scalp condition.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Congenital atrichia with papular lesions causes permanent hair loss in children.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

The role of γδT-cells in causing alopecia areata remains unclear.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Adolescents with severe alopecia incur significantly higher healthcare costs.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

Androgenic alopecia can be treated with minoxidil, finasteride, and hormonal therapy.

Denosumab may cause alopecia areata.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

An 8-year-old girl has a rare genetic disorder causing complete, irreversible hair loss and skin bumps.

Alopecia areata is an autoimmune disease causing hair loss, with treatments often ineffective but new options are being researched.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Ritlecitinib may help young adults with severe alopecia areata when ketoconazole fails.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

A woman's hair loss was due to trichotillomania, which is often misdiagnosed and can require different treatments based on age and underlying conditions.

African American adults and non-White children experience more hair loss episodes than White patients with alopecia areata.

A man had an unusual type of hair loss that didn't match known patterns and didn't improve with treatment.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.